✦ LIBER ✦

Melatonin add-on in manic patients with treatment resistant insomnia

✍ Scribed by Giuseppe Bersani; Alessandra Garavini

Book ID: 117449572
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 439 KB
Volume: 24
Category: Article
ISSN: 0278-5846
DOI: 10.1016/s0278-5846(99)00097-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.1.136 Melatonin add-on in manic patien

P.1.136 Melatonin add-on in manic patients with treatment resistant insomnia

✍ G. Bersani 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Oxcarbazepine as add-on treatment in pat

Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode

✍ Alessandra Benedetti; Lorenzo Lattanzi; Stefano Pini; Laura Musetti; Liliana Del 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Treatment-resistant residual insomnia in

Treatment-resistant residual insomnia in patients with recurrent major depressive episodes

✍ Shinobu IWAKI; Kohtoku SATOH; Yasuhiro MATSUMOTO; Masaru ECHIZENYA; Tomonori KAT 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB

Vigabatrin as first add-on treatment in

Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients

✍ L. Murri; A. Ludice 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Huperzine A as add-on therapy in patient

Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: An open-labeled trial

✍ Zhang-Jin Zhang; Yao Tong; Xue-Yi Wang; Shao-Min Yao; Gui-Xing Jin; Xiao-Ping Wa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Efficacy and safety evaluation of lorecl

Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients

✍ T Rentmeester; J Hulsman 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Thirteen drug-resistant epilepsy patients received loreclezole as add-on therapy. The trial lasted 6 months. Loreclezole was dosed to reach a target plasma concentration between 1 and 3 mg/l. The seizure frequency in the total group decreased by 23%. A reduction of 50% or more was observed in four p